Fighting pediatric cancer focus of V Foundation-UF Health collaboration
In pursuit of its ongoing mission to achieve Victory Over Cancer®, the V Foundation for Cancer Research announced its renewed support and a new $250,000 grant for the University of Florida’s efforts to combat brain cancer in children. Combined with private support, a total of $600,000 in new funding will bolster critical research programs.
UF researchers evaluate how to improve dignity for seriously ill patients
Hearing that you have a life-threatening illness can be physically and emotionally challenging. And while great strides have been made in helping people with a terminal illness manage their physical symptoms toward the end of their lives, helping them cope with the accompanying emotional distress is another story.
UF Scripps researcher’s drug-discovery method shows promise against aggressive breast cancer
UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA. Until now, RNA has been an elusive target for drug discovery. Discoveries made by Disney and his collaborators have rewritten that dogma.
Florida cancer hospitals get $100 million for research
Gov. Ron DeSantis announced that he will approve $100 million for cancer research and treatment in the state’s 2022-2023 spending plan — an increase of about $37 million over the current budget. Three Florida cancer centers — the UF Health Cancer Center, Sylvester Comprehensive Cancer Center and H. Lee Moffitt Cancer Center and Research Institute — will receive the funding for research and medical care.
UF to test novel CAR-modified T-cell technique in clinical trial for glioblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test an investigational new therapy in a first-in-human clinical trial for participants with primary glioblastoma, the most aggressive malignant brain tumor.
SynGatorTron™ to speed medical research, alleviate privacy worries
“Dr. Chatbot will see you now.”
The next generation of super-smart computers, tablets and cell phones may come equipped with artificial intelligence-generated medical chatbots that can interact with patients using human language and medical knowledge.
Researchers’ discovery advances knowledge of key cellular function
The role of ribosomes in converting genetic code into protein molecules is well known. Despite that, much less is known about how ribosomes arise. More surprisingly, recent discoveries have indicated different “flavors” of ribosomes produce different proteins.
Now, researchers at Scripps Research’s Florida campus have discovered how normal ribosomes are “remodeled” into different subtypes as a response to cellular stress.
Janice Krieger, CJC doctoral student and colleagues co-author article on colorectal cancer screening message strategies
According to the authors: “The current study demonstrated that a tailored risk message increased perceptions of message relevance and susceptibility to colorectal cancer, which increased patient intentions to screen for colorectal cancer. Findings offer a low-burden, practical approach to evaluate and improve health education materials that promote screening.”
UF Health spearheading simulator-based mastery training for prostate biopsies
Traditional prostate biopsies don’t have the greatest track record when it comes to catching cancers, as various studies report a false negative rate ranging from 21-47%. That’s why the urologists at the University of Florida are pioneering a simulation-based mastery training in prostate biopsy with the goal of improving those statistics.
Study shows TTFields holds promise to potentially trigger immune response against GBM recurrence
University of Florida neuroscientists have discovered a new potential benefit of a form of electric fields therapy currently in use to treat glioblastoma, the deadliest form of brain cancer in adults.
New targeted therapy for prostate cancer now available at UF Health Radiation Oncology – Davis Cancer Pavilion
Pluvicto, a targeted therapy for progressive, PSMA-positive metastatic castration-resistant prostate cancer, has been approved for clinical use by the FDA. On April 26, UF Health Radiation Oncology became the first in the state of Florida to administer it to patients.
